SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-041658
Filing Date
2021-08-05
Accepted
2021-08-05 16:41:00
Documents
72
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q cdak-10q_20210630.htm   iXBRL 10-Q 2986609
2 EX-31.1 cdak-ex311_6.htm EX-31.1 19941
3 EX-31.2 cdak-ex312_8.htm EX-31.2 20257
4 EX-32.1 cdak-ex321_7.htm EX-32.1 16978
  Complete submission text file 0001564590-21-041658.txt   10384373

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA cdak-20210630.xsd EX-101.SCH 83455
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cdak-20210630_cal.xml EX-101.CAL 62733
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cdak-20210630_def.xml EX-101.DEF 211785
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE cdak-20210630_lab.xml EX-101.LAB 562003
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cdak-20210630_pre.xml EX-101.PRE 394650
10 EXTRACTED XBRL INSTANCE DOCUMENT cdak-10q_20210630_htm.xml XML 2006088
Mailing Address 35 CAMBRIDGEPARK DRIVE SUITE 500 CAMBRIDGE MA 02140
Business Address 35 CAMBRIDGEPARK DRIVE SUITE 500 CAMBRIDGE MA 02140 617-949-4100
Codiak BioSciences, Inc. (Filer) CIK: 0001659352 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39615 | Film No.: 211149011
SIC: 2836 Biological Products, (No Diagnostic Substances)